Drug Makers To Face Stricter Audits, Surprise Inspections As ‘Schedule M’ Quality Rules Come Into Effect

According to the letter sent by the drug regulator general of India (DCGI), Rajeev Singh Raghuvanshi, seen by News18, the licensed premises must be inspected by both a central and a state inspector at least once every three years or more often if needed